Clinical trial
Clinical and Angiographic Outcomes With Hyperglycemic Control Post PCI
NCT00412126 · Hamilton Health Sciences Corporation, Other · Completed
Key facts
| NCT number | NCT00412126 |
|---|---|
| Title | Clinical and Angiographic Outcomes With Hyperglycemic Control Post PCI |
| Official title | Does Reduction of Hyperglycemia With Insulin Impact Restenosis and Improve Clinical Outcomes Following PCI? |
| Lead sponsor | Hamilton Health Sciences Corporation, Other |
| Collaborators | Heart and Stroke Foundation of Canada |
| Status | Completed |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Coronary Restenosis |
| Intervention type | Drug |
| Interventions | Insulin |
| Enrollment | 240 |
| Start date | Jul 1, 2002 |
| Completion | Sep 1, 2005 |
| First posted | Dec 15, 2006 |
| Last update posted | Dec 15, 2006 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: